Purpose: to evaluate the safety and tolerability of different formulations of an FDA approved medication.
Participate in a clinical study for the treatment of cardiomyopathy.
This is a clinical study to assess the similarity of 1x 15mg dose versus 3x 5mg dose of mavacamten for the treatment of cardiomyopathy.
This study is to assess how a capsule is processed in the body when given different formulations of an FDA approved medication.
This study has two separate admits each of 4 nights and 5 days & 11 outpatient visits over 4 months.
Reimbursement for study participation will be provided for time and travel of up to $8,750.
This study has been reviewed and approved by an independent ethics committee.
This study requires adults willing to adhere to the contraception requirements for this study.
Call 612-315-6490 to discuss your eligibility today!